GSK Plc (NYSE:GSK) has filed a lawsuit against Moderna, Inc. (NASDAQ:MRNA) and its affiliates, alleging that Moderna’s mRNA vaccines infringe on patents developed by GSK.
According to GSK, the technology used in Moderna’s vaccines, including its Spikevax family of vaccines, is based on a platform created by the team led by vaccinologist Christian Mandl.
GSK claims Moderna has profited billions from using this technology without proper acknowledgment or licensing.
GSK asserts that its scientists, including Christian Mandl, Andrew Geall, and others, pioneered mRNA vaccine technology more than a decade before the COVID-19 pandemic.
These scientists developed formulations combining lipids and mRNA molecules to create vaccines that trigger immune responses ...
